Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country

被引:9
|
作者
Thitisuriyarax, Saranya [1 ]
Vanichanan, Jakapat [2 ]
Udomkarnjananun, Suwasin [3 ]
Townamchai, Natavudh [4 ]
Jutivorakool, Kamonwan [2 ]
机构
[1] Chulalongkorn Univ, Dept Med, Fac Med, Bangkok, Thailand
[2] King Chulalongkorn Mem Hosp, Div Infect Dis, Dept Med, Bangkok 10330, Thailand
[3] King Chulalongkorn Mem Hosp, Div Nephrol, Dept Med, Bangkok, Thailand
[4] Chulalongkorn Univ, Div Nephrol, Dept Med, Fac Med, Bangkok, Thailand
关键词
allograft rejection; kidney transplant; risk factors; tuberculosis; INFECTION; STATEMENT; DISEASES; SOCIETY;
D O I
10.1111/tid.13566
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Tuberculosis (TB) is considered as a challenge issue in solid organ transplant recipients because of high morbidity and mortality. Active TB after transplant mostly occurs from reactivation of latent infection. Understanding risk factors and clinical information of TB may provide an appropriate prevention and treatment strategies in this specific patient population, however data from high endemic area is scarce. Methods A matched single-center, case-control study was conducted in our institute. Cases were defined as newly diagnosed confirmed or clinical active TB in patients who underwent kidney transplant (KT) between April 1992 and October 2018. For each case, 5 controls were matched by age and sex. Risk factor associated with TB was determined using univariate and multivariate conditional logistic regression. Results Between study period, KT was performed in 787 patients. Twenty-seven patients (3.43%) were diagnosed with active TB including 20 confirmed and 7 clinical diagnosed cases. The global incidence of TB in our population was 315 cases per 100 000 patients per year. Among 27 cases, pulmonary involvement was the most common (48.1%) followed by disseminated (18.5%), extrapulmonary (14.8%), pleura (11.1%) and pleuropulmonary (7.4%) TB. Allograft rejection was significantly associated with active TB (P < .001). The median onset duration of infection was 17 months (IQR, 4-59 months) after KT. Twenty-four (88.9%) patients received rifampicin containing regimen for treatment with median duration of 10 months (IQR, 6-12 months). All patients were cured after complete treatment, however those with TB remained having unfavorable outcomes including higher all-cause mortality and graft loss. Conclusions Incidence rate of TB in KT recipients is higher than normal population. Allograft rejection was identified as a significant risk factor. Increase unfavorable outcomes including graft loss and mortality were also observed among patients with TB.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Evaluation of a Screening Program for Tuberculosis in Kidney Transplant Recipients in an Endemic Country
    Arreola-Guerra, J. M.
    Perez, M. C.
    Avila-Cervantes, R.
    Alberu, J.
    Sifuentes-Osornio, J.
    Correa-Rotter, R.
    Villasis-Keever, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 210 - 210
  • [2] The risk factors for tuberculosis in liver or kidney transplant recipients
    Jia Liu
    Jin Yan
    Qiquan Wan
    Qifa Ye
    Yisheng Huang
    [J]. BMC Infectious Diseases, 14
  • [3] The risk factors for tuberculosis in liver or kidney transplant recipients
    Liu, Jia
    Yan, Jin
    Wan, Qiquan
    Ye, Qifa
    Huang, Yisheng
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [4] Incidence and Outcomes of Tuberculosis among Thoracic Organ Transplant Recipients in an Endemic Country-15 Years of Evaluation
    Campos, S. V.
    Pola Dos Reis, F.
    Pires, J. P.
    Lima, M. L.
    Abdalla, L. G.
    Cury, C. B.
    Fernandes, L. M.
    Teixeira, R. B.
    Costa, A. N.
    Carraro, R. M.
    Bacal, F.
    Pego-Fernandes, P. M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S337 - S337
  • [5] Risk Factors for and Outcomes of Orthostatic Hypotension Among Simultaneouspancreas and Kidney Transplant Recipients
    Aziz, F.
    Mandelbrot, D.
    Jorgenson, M.
    Muth, B.
    Baltaji, A.
    Pantha, M.
    Kaufman, D.
    Odorico, J.
    Parajuli, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1043 - S1044
  • [6] Lymphoceles in Kidney Transplant Recipients: Incidence, Risk Factors, Outcomes, and Clinical Management
    Kim, J.
    Nguyen, E.
    Minkovich, M.
    Famure, O.
    Li, Y.
    Lee, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 606 - 606
  • [7] Risk Factors and Outcomes of Neutropenia in Kidney Transplant Recipients
    Avery, R.
    Motter, J.
    Sae-Tia, S.
    Lu, N.
    Cochran, W.
    Massie, A.
    Brennan, D.
    Akinwande, F.
    Shoham, S.
    Kraus, E.
    Alachkar, N.
    Alasfar, S.
    Naqvi, F.
    Al Ammary, F.
    Marr, K.
    Steinke, S. Mehta
    Desai, N.
    Ezennia, O.
    Plummer, P.
    Durand, C.
    Werbel, W.
    Kim, M. Y.
    Segev, D.
    Wang, J. Garonzik
    Trollinger, B.
    Lees, L.
    Toman, L.
    Shulder, S.
    Dzintars, K.
    Ostrander, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 601 - 602
  • [8] Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes
    Brar, S.
    Wang, Y.
    Cannitelli, A.
    Li, Y.
    Famure, O.
    Husain, S.
    Kim, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 471 - 472
  • [9] NEUTROPENIA IN KIDNEY AND LIVER TRANSPLANT RECIPIENTS: RISK FACTORS AND OUTCOMES
    Mavrakanas, T.
    Fournier, M. A.
    Clairoux, S.
    Amiel, J. A.
    Tremblay, M. E.
    Vinh, D. C.
    Coursol, C.
    Thirion, D. J. G.
    Cantarovich, M.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 176 - 177
  • [10] Neutropenia in kidney and liver transplant recipients: Risk factors and outcomes
    Mavrakanas, Thomas A.
    Fournier, Marie-Andree
    Clairoux, Sarah
    Amiel, Jacques-Alexandre
    Tremblay, Marie-Eve
    Vinh, Donald C.
    Coursol, Christian
    Thirion, Daniel J. G.
    Cantarovich, Marcelo
    [J]. CLINICAL TRANSPLANTATION, 2017, 31 (10)